CAH vs LNTH
CAH: Cardinal Health is a major healthcare services provider connecting manufacturers and healthcare providers through its extensive pharmaceutical and medical supply chain distribution network. LNTH: Lantheus is a specialist in diagnostic imaging agents and radiopharmaceuticals that help clinicians visualize cardiovascular conditions and oncological disease states.
Side-by-side fundamentals
| Metric | CAH | LNTH | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $238.96 | $100.12 | |
| Market cap | $55.6B | $6.5B | |
| P/E as of 2026-10-08 | 36.52 | 24.22 | LNTH lower |
| Net margin | +0.7% | +15.2% | LNTH higher |
| Gross margin | +3.8% | +61.1% | LNTH higher |
| Operating margin | +1.0% | +20.2% | LNTH higher |
| ROE FY2025, SEC XBRL | n/a | +21.4% | |
| ROA | +3.0% | +10.5% | LNTH higher |
| Debt / equity as of 2026-09-03 | 5.65 | 0.44 | LNTH lower |
| Revenue growth (YoY) as of 2026-09-03 | +12.9% | +2.4% | CAH higher |
| Revenue CAGR (3y) SEC XBRL | +7.4% | +18.1% | LNTH higher |
| Dividend yield as of 2026-09-03 | +0.9% | n/a | |
| Dividend streak (yrs) SEC XBRL | 19 | 0 | CAH higher |
| Beta as of 2026-09-03 | 0.27 | 0.38 | |
| 1-year return as of 2026-10-08 close | +51.5% | +87.0% | LNTH higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.